Anti-HGF/SF [EGH2 4C12.1]
Invented at University of Cambridge
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151213 |
| Applications | ELISA IHC WB |
| Antigen/Gene or Protein Targets | Hepatocyte Growth Factor/Scatter Factor (HGF/SF) |
| Reactivity | Human |
| Relevance | HGF/SF is a member of the plasminogen related growth factor family, members of which are potent effectors of growth, movement and differentiation of epithelial and endothelial cells. HGF/SF may exhibit morphogenesis in adjacent cells. The membrane receptor for HGF/SF is the product of the proto-oncogene c-met, a receptor tyrosine kinase. |
| Host | Mouse |
| Immunogen | Recombinant Human HGF/SF |
| Positive Control | Recombinant HGF/SF |
| Subclass | IgG2b |
| Myeloma Used | NS0 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Research Area | Cancer, Cell Signaling & Signal Transduction |
References: 2 entries
Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation; Bai et al. 2017. Exp Ther Med. 13(6):2876-2882. PMID: 28587353.
IHC
In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor; Arends et al. 2008. Vet J. 178(1):70-7. PMID: 18314358.
ELISA WB
Add a reference
References: 2 entries
Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation; Bai et al. 2017. Exp Ther Med. 13(6):2876-2882. PMID: 28587353.
IHC
In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor; Arends et al. 2008. Vet J. 178(1):70-7. PMID: 18314358.
ELISA WB
Add a reference
